Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Allogene Therapeutics Inc’s stock clocked out at $2.21, up 4.74% from its previous closing price of $2.11. In other words, the price has increased by $4.74 from its previous closing price. On the day, 1.42 million shares were traded. ALLO stock price reached its highest trading level at $2.23 during the session, while it also had its lowest trading level at $2.09.
Ratios:
To gain a deeper understanding of ALLO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.35 and its Current Ratio is at 9.35. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 21 ’24 when Parker Geoffrey M. bought 36,404 shares for $2.84 per share.
Douglas Earl Martin bought 28,310 shares of ALLO for $78,844 on Aug 21 ’24. On Jun 18 ’24, another insider, MESSEMER DEBORAH M., who serves as the Director of the company, sold 18,641 shares for $2.28 each. As a result, the insider received 42,488 and left with 166,765 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 463375136 and an Enterprise Value of 264335328. For the stock, the TTM Price-to-Sale (P/S) ratio is 12133.53 while its Price-to-Book (P/B) ratio in mrq is 1.00. Its current Enterprise Value per Revenue stands at 6147.333 whereas that against EBITDA is -1.037.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $1.99. The 50-Day Moving Average of the stock is -17.74%, while the 200-Day Moving Average is calculated to be -28.93%.
Shares Statistics:
It appears that ALLO traded 2.09M shares on average per day over the past three months and 2420300 shares per day over the past ten days. A total of 167.13M shares are outstanding, with a floating share count of 142.43M. Insiders hold about 32.07% of the company’s shares, while institutions hold 68.24% stake in the company. Shares short for ALLO as of 1730332800 were 37040821 with a Short Ratio of 17.73, compared to 1727654400 on 38512665. Therefore, it implies a Short% of Shares Outstanding of 37040821 and a Short% of Float of 24.870001.
